BREMEN Eye Drops Versus Combigan for Open-angle Glaucoma or Intraocular Hypertension
Status:
Recruiting
Trial end date:
2023-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the clinical efficacy of the BREMEN eye drops in the
treatment of primary open-angle glaucoma or intraocular hypertension.
Phase:
Phase 3
Details
Lead Sponsor:
EMS
Treatments:
Brimonidine Tartrate, Timolol Maleate Drug Combination Brinzolamide Ophthalmic Solutions Tetrahydrozoline